GREY:BIOAF - Post by User
Comment by
prophetoffactzon Jan 12, 2023 1:28pm
85 Views
Post# 35218928
RE:RE:(AIM:MTPH.L)(Nasdaq:MTP) MTX-110 Ph1 Study Update
RE:RE:(AIM:MTPH.L)(Nasdaq:MTP) MTX-110 Ph1 Study Update"I assume the deal will be re-evaluted before Feb, 3rd,,we will be diluted back to 1% or less in that scenario!!"
The S&P Biotech ETF is now at a 4 month high on declining inflation fears giving some nice tone to the market in general. Midatech on the London Stock Exchange is up about 22% in the last five days. Midatech on NASDAQ is down ~27% in the last five days. It looks like there is aggressive dumping into the bid on Midatech on NASDAQ this week for whatever reason. The bid/ask spread can be quite large.
If Midatch's stock price is below $.90 Midatech can walk away from the Armistice financing. The CEO, if I remember correctly, said he could have put together a syndicate as an option. It will be interesting to see what happens. The multi-product J&J option on xB3 expires a few days before BTI's shareholder vote.